Victory Capital Management Inc. Purchases 6,426 Shares of Novanta Inc. $NOVT

Victory Capital Management Inc. increased its position in shares of Novanta Inc. (NASDAQ:NOVT) by 4.5% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 148,113 shares of the technology company’s stock after purchasing an additional 6,426 shares during the quarter. Victory Capital Management Inc. owned approximately 0.41% of Novanta worth $14,834,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in NOVT. Pilgrim Partners Asia Pte Ltd bought a new stake in Novanta during the third quarter worth about $36,000. Migdal Insurance & Financial Holdings Ltd. bought a new position in shares of Novanta in the third quarter valued at approximately $40,000. Harbor Investment Advisory LLC boosted its holdings in shares of Novanta by 47.1% in the 3rd quarter. Harbor Investment Advisory LLC now owns 987 shares of the technology company’s stock worth $99,000 after acquiring an additional 316 shares in the last quarter. Inceptionr LLC bought a new stake in Novanta during the 2nd quarter worth approximately $213,000. Finally, Blueshift Asset Management LLC acquired a new stake in Novanta during the 2nd quarter valued at $213,000. 98.35% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Novanta news, CFO Robert Buckley sold 1,423 shares of the company’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $140.88, for a total transaction of $200,472.24. Following the transaction, the chief financial officer directly owned 93,814 shares in the company, valued at approximately $13,216,516.32. This represents a 1.49% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Matthijs Glastra sold 7,500 shares of the firm’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $145.04, for a total transaction of $1,087,800.00. Following the completion of the transaction, the chief executive officer directly owned 57,367 shares in the company, valued at $8,320,509.68. This trade represents a 11.56% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 24,346 shares of company stock valued at $3,382,737 over the last three months. Company insiders own 1.20% of the company’s stock.

Novanta Stock Down 3.2%

Shares of NOVT opened at $123.14 on Wednesday. The business’s fifty day moving average price is $135.02 and its two-hundred day moving average price is $121.13. The firm has a market capitalization of $4.39 billion, a price-to-earnings ratio of 84.34 and a beta of 1.61. Novanta Inc. has a 52 week low of $98.27 and a 52 week high of $149.95. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.80 and a current ratio of 3.69.

Novanta (NASDAQ:NOVT) last released its earnings results on Monday, February 23rd. The technology company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.88 by $0.03. The company had revenue of $258.35 million during the quarter, compared to the consensus estimate of $260.72 million. Novanta had a return on equity of 13.12% and a net margin of 5.49%.During the same quarter in the previous year, the company posted $0.76 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. On average, analysts predict that Novanta Inc. will post 3.03 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on NOVT shares. Weiss Ratings raised Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, January 20th. Zacks Research upgraded shares of Novanta from a “strong sell” rating to a “hold” rating in a research report on Friday, January 16th. Finally, Robert W. Baird set a $150.00 price objective on shares of Novanta in a report on Wednesday, February 25th. Three research analysts have rated the stock with a Hold rating, According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $150.00.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.